Saturday, 21 September 2019

Sartorius Stedim ( Single-Use Modules Expedite Total Solutions )

20 June 2019 | Analysis

Sponsored By : Sartorius Stedim

 Single-Use Modules Expedite Total Solutions 


As the biopharmaceutical industry continues to grow at a rapid pace, companies are realizing that they may need to transform their biomanufac-turing networks to respond to changing market dynamics and anticipate customer requirements. A major factor behind the growth of the biopharma-ceutical industry has been the huge and continued success of the monoclonal antibodies segment. Within the industry, however, companies have started to diversify their pipelines, developing products such as antibody-drug conju-gates, non-antibody recombinant proteins, gene therapies, and autologous and allogenic cell therapies.


Click here to access white paper


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls